Macrophage-related inflammation has been identified as a possible predictor of the success or failure of implants based on their polarization of the pro-inflammatory/anti-inflammatory (M1/M2) phenotype. The purpose of this study was to deliver interleukin 4 (IL-4, a cytokine that triggers M2 polarization of macrophages) from a titanium substrate by a graphene oxide (GO) coating to regulate the macrophage-related inflammatory response and improve the implant performance. The GO/IL-4 coating showed good biocompatibility and promoted macrophages polarization to the M2 phenotype . Conditioned media from macrophages cultured on a GO/IL-4 surface promoted the proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). As the inflammatory response at the interface of GO/IL-4 weakened, the percentage of M2-polarized macrophages increased and the best stability, bone-implant contact, and osteogenesis were observed . These results demonstrate that the macrophage-related inflammatory response plays a crucial role in osteogenesis around implants and that this GO/IL-4 coating provides an effective strategy for promoting implant osseointegration by regulating immune function.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsbiomaterials.0c01011DOI Listing

Publication Analysis

Top Keywords

inflammatory response
12
titanium substrate
8
graphene oxide
8
osseointegration regulating
8
macrophage-related inflammatory
8
go/il-4 coating
8
delivery interleukin
4
interleukin titanium
4
substrate coated
4
coated graphene
4

Similar Publications

Effects of Chemical Pretreatments of Wood Cellulose Nanofibrils on Protein Adsorption and Biological Outcomes.

ACS Appl Mater Interfaces

January 2025

Center of Translational Oral Research (TOR), Department of Clinical Dentistry, University of Bergen, Bergen 5009, Norway.

Wood-based nanocellulose is emerging as a promising nanomaterial in the field of tissue engineering due to its unique properties and versatile applications. Previously, we used TEMPO-mediated oxidation (TO) and carboxymethylation (CM) as chemical pretreatments prior to mechanical fibrillation of wood-based cellulose nanofibrils (CNFs) to produce scaffolds with different surface chemistries. The aim of the current study was to evaluate the effects of these chemical pretreatments on serum protein adsorption on 2D and 3D configurations of TO-CNF and CM-CNF and then to investigate their effects on cell adhesion, spreading, inflammatory mediator production , and the development of foreign body reaction (FBR) .

View Article and Find Full Text PDF

Regulated sequential exocytosis of neutrophil granules is essential in orchestrating the innate immune response, while uncontrolled secretion causes inflammation. We developed and characterized Nexinhib20, a small-molecule inhibitor that targets azurophilic granule exocytosis in neutrophils by blocking the interaction between the small GTPase Rab27a and its effector JFC1. Its therapeutic potential has been demonstrated in several pre-clinical models of inflammatory disease.

View Article and Find Full Text PDF

Potential trend of regenerative treatment for type I diabetes has been introduced for more than a decade. However, the technologies regarding insulin-producing cell (IPC) production and transplantation are still being developed. Here, we propose the potential IPC production protocol employing mouse gingival fibroblast-derived induced pluripotent stem cells (mGF-iPSCs) as a resource and the pre-clinical approved subcutaneous IPC transplantation platform for further clinical confirmation study.

View Article and Find Full Text PDF

Objectives: The relationship between proteomic profiles and incident systemic lupus erythematosus (SLE) remains unclear. We aimed to identify candidate plasma proteins for SLE risk in women, discover potential treatment targets for SLE, and develop and validate a protein-based prediction model for SLE risk.

Methods: 28 220 women from the UK Biobank were randomly split into training (70%) and testing (30%) sets.

View Article and Find Full Text PDF

Background: Randomised controlled trials (RCTs) evaluating new systemic treatments for atopic dermatitis (AD) have increased dramatically over the last decade. These trials often incorporate topical therapies either as permitted concomitant or rescue treatments. Differential use of these topicals post-randomisation introduces potential bias as they may nullify or exaggerate treatment responses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!